Search & Analyze

Dr. Lal Pathlabs Ltd.

HealthcareHospital & Healthcare Services

www.lalpathlabs.com BSE: 539524NSE: LALPATHLAB

₹1,885.75BSE2.41%

16 Sep, 4:01 PM

₹1,885.75

₹31.79K Cr

58.67

12.17

22.37%

₹2,035.00

₹1,872.85

₹2,035.00

₹1,272.00

Customise metrics bar

Price Performance

Peer Comparison

Name
APOLLO HOSP. APOLLOHOSP	8,712.95	59.96	1,25,278.85	0.23	610.40	38.41%	7,043.50	20.56%	21.73
MAXHEALTH MAXHEALTH	1,032.60	68.98	1,00,504.02	0.19	322.96	4.87%	2,366.17	16.70%	14.97
MANIPALHOS MANIPALHOS	714.45	105.32	93,977.12	0.00	243.43	-4.18%	3,090.63	38.12%	13.93
FORTIS FORTIS	868.50	62.57	65,568.12	0.12	272.80	2.26%	2,545.03	17.46%	14.07
ASTERDM ASTERDM	740.00	202.67	64,503.76	0.40	29.28	-68.70%	1,310.68	21.60%	16.22
NH NH	1,855.25	46.37	37,914.04	0.24	207.27	5.37%	2,683.63	78.05%	16.20
MEDANTA MEDANTA	1,406.40	67.92	37,814.13	0.04	157.25	-1.09%	1,304.05	26.50%	19.38
Dr. Lal Pathlabs Ltd. LALPATHLAB	1,885.75	58.67	31,790.57	1.08	170.50	27.24%	797.70	19.10%	29.56

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	601.90	660.20	596.70	602.60	669.80	730.60	659.80	702.70	797.70
Expenses	431.90	457.70	442.70	433.60	477.50	506.50	480.50	515.90	550.20
	170.00	202.50	154.00	169.00	192.30	224.10	179.30	186.80	247.50
	28.24%	30.67%	25.81%	28.05%	28.71%	30.67%	27.17%	26.58%	31.03%
	20.60	21.90	25.10	25.80	28.10	24.80	-5.70	24.00	31.90
Interest	6.00	6.00	5.30	5.00	4.70	4.80	7.20	6.10	6.30
	34.70	35.30	35.50	36.40	34.60	40.50	42.10	44.60	44.40
	149.90	183.10	138.30	153.40	181.10	203.60	124.30	160.10	228.70
	28.09%	28.56%	29.07%	-1.37%	26.01%	25.25%	26.47%	17.43%	25.45%
	106.40	129.20	96.70	154.80	132.40	150.60	90.50	131.30	169.50
	12.74	15.45	11.57	18.52	15.80	17.97	5.40	7.83	10.11

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME:
Operating Income	2,087.41	2,016.88	2,226.64	2,461.40	2,762.91
Operating Income (Net)	2,087.41	2,016.88	2,226.64	2,461.40	2,762.91
EXPENDITURE :
Cost of Medicines and Consumables	502.25	447.15	451.42	481.46	534.62
Power & Fuel Cost	22.11	25.91	26.18	27.16	28.25
Employee Cost	364.94	376.52	424.57	455.78	503.26
Hospital Operation Expenses	361.63	385.55	423.24	468.05	530.86
Selling, Administration and Other Expenses	229.30	233.04	236.97	281.88	327.60
Miscellaneous Expenses	46.45	58.88	55.02	51.46	55.80
	1,526.68	1,527.05	1,617.40	1,765.80	1,980.40
Operating Profit (Excl OI)	560.73	489.83	609.24	695.60	782.52
	52.55	41.72	69.17	93.43	101.27
	613.27	531.55	678.41	789.03	883.78
Interest	30.18	37.53	29.36	22.31	22.80
PBDT	583.09	494.02	649.05	766.72	860.98
	108.11	150.19	143.60	141.92	161.80
Profit Before Taxation & Exceptional Items	474.98	343.83	505.45	624.80	699.18
Exceptional Income / Expenses					-30.09
	474.98	343.83	505.45	624.80	669.09
Provision for Tax	124.69	102.75	143.16	132.55	159.33
	350.29	241.08	362.29	492.25	509.75
Extra items		0.00	0.00	0.00	0.00
Minority Interest	-5.46	-2.23	-4.56	-5.11	-4.98
Consolidated Net Profit	344.83	238.85	357.74	487.14	504.78
Profit Balance B/F	981.85	1,209.69	1,418.70	1,576.64	1,859.96
Appropriations	1,326.69	1,448.53	1,776.43	2,063.78	2,364.74
Equity Dividend %	120.00%	120.00%	240.00%	240.00%	205.00%
	41.37	28.65	42.85	58.28	30.13
Adjusted EPS	20.69	14.32	21.43	29.14	30.13

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	83.35	83.37	83.48	83.59	167.56
Share Warrants & Outstandings	58.29	58.26	51.15	56.64	66.05
Total Reserves	1,359.98	1,524.67	1,714.66	2,032.48	2,274.53
Reserve excluding Revaluation Reserve	1,359.98	1,524.67	1,714.66	2,032.48	2,274.53
Revaluation reserve			0.00
	1,501.61	1,666.30	1,849.28	2,172.72	2,508.14
Minority Interest	35.46	33.25	36.08	33.76	33.14
Secured Loans	166.67	83.33
Unsecured Loans	0.13
Deferred Tax Assets / Liabilities	-33.00	-37.48	-42.47	-83.24	-81.51
Other Long Term Liabilities	138.86	129.99	103.02	102.64	145.42
Long Term Provisions			1.61	1.95	2.65
Total Non-Current Liabilities	272.66	175.84	62.16	21.34	66.56
Trade Payables	147.38	156.10	186.57	167.05	180.60
Other Current Liabilities	226.98	214.02	227.46	186.31	189.17
Short Term Borrowings	95.42	70.00
Short Term Provisions	30.20	29.63	49.55	48.99	80.85
Total Current Liabilities	499.99	469.75	463.58	402.35	450.62
Total Liabilities	2,309.71	2,345.14	2,411.10	2,630.17	3,058.46
Gross Block	1,726.23	1,807.22	1,828.44	1,903.54	2,146.43
Less: Accumulated Depreciation	357.42	502.16	634.62	768.56	922.86
Net Block	1,368.81	1,305.06	1,193.83	1,134.99	1,223.57
Capital Work in Progress	14.45	2.97	3.95	3.48	5.49
Long Term Investment			0.00
Long Term Loans & Advances	39.89	35.21	31.26	26.66	33.32
Other Non Current Assets	10.86	26.84	19.97	68.18	195.76
Total Non-Current Assets	1,434.56	1,372.05	1,284.41	1,266.66	1,491.97
Currents Investments	65.46	149.94	113.78	326.70	422.59
Inventories	52.54	33.81	37.31	36.13	43.86
Sundry Debtors	85.40	70.82	77.40	88.12	110.69
Cash and Bank	617.59	665.41	830.31	838.68	909.54
Other Current Assets	33.83	34.38	47.89	50.89	53.37
Short Term Loans and Advances	20.34	18.72	20.01	23.00	26.45
Total Current Assets	875.15	973.09	1,126.70	1,363.51	1,566.49
Net Current Assets (Including Current Investments)	375.16	503.33	663.12	961.16	1,115.88
Total Assets	2,309.71	2,345.14	2,411.10	2,630.17	3,058.46
Contingent Liabilities	13.18	13.64	10.09	10.59	16.76
Total Debt	345.65	236.67	83.33	0.00	0.00
	173.17	192.88	215.40	253.14	145.75
Adjusted Book Value	86.59	96.44	107.70	126.57	145.75

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	474.98	343.83	505.45	624.80	669.09
Adjustment	118.45	183.16	126.18	106.86	115.29
Changes In working Capital	-16.71	35.48	35.74	1.12	26.62
Cash Flow after changes in Working Capital	576.72	562.46	667.37	732.78	810.99
Cash Flow from Operating Activities	446.69	456.03	535.33	568.89	635.61
Cash Flow from Investing Activities	-449.25	-287.31	-24.27	-303.16	-421.86
Cash Flow from Financing Activitie	136.45	-283.18	-413.86	-334.03	-263.57
Net Cash Inflow / Outflow	133.90	-114.46	97.20	-68.31	-49.83
Opening Cash & Cash Equivalents	244.30	378.20	263.73	360.93	292.63
Closing Cash & Cash Equivalent	378.20	263.73	360.93	292.63	242.80

Ratios

Valuation

58.67

12.17

32.75

11.00

32.29

155.67

Profitability

22.37

29.56

17.92

28.32

18.45

Leverage & Liquidity

0.00

3.48

30.35

Returns

1.08

0.97

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26
	54.60	53.92	53.91	53.91	53.79	53.21	53.21	53.21	53.19
	38.13	39.71	39.99	39.99	39.47	40.20	39.36	38.43	38.82
	7.26	6.37	6.11	6.10	6.74	6.58	7.43	8.35	7.99
	45.40	46.08	46.09	46.09	46.21	46.79	46.79	46.79	46.81
No. of Shareholders	1,31,189	1,16,606	1,16,236	1,15,699	1,18,656	1,12,703	1,16,167	1,14,527	1,11,037

Corporate Actions

Showing: All

Date	Type	Details	Ex-Date	Record Date
2026-07-24	Ex Dividend	Rs.5.0000 per share(50%)Interim Dividend	2026-07-30	2026-07-30
2026-06-29	Board Meeting	Quarterly Results
2026-04-30	Ex Dividend	Rs.4.0000 per share(40%)Final Dividend	2026-06-25	2026-06-26

Insider Trading

Date	Person	Category	Transaction Type	Shares
2026-09-15	Nitish Rehal	Market	Sell	400
2026-09-15	Mrinal Kapoor	Market	Sell	2,000
2026-09-15	Nitish Rehal	ESOP	Buy	400
2026-09-08	Sanjay Kulshreshtha	ESOP	Buy	500
2026-09-08	Lal PathLabs Employee Welfare Trust	ESOP	Sell	3,000
2026-09-08	Sanjay Kulshreshtha	Market	Sell	500
2026-09-03	Lal PathLabs Employee Welfare Trust	ESOP	Sell	5,700
2026-09-03	Amit Aggarwal	Market	Sell	1,500
2026-09-03	Amit Aggarwal	ESOP	Buy	1,500
2026-09-03	Jai Prakash Meena	ESOP	Buy	2,000
2026-08-25	Abhishek Maini	Market	Sell	500
2026-08-25	Abhishek Maini	ESOP	Buy	500
2026-08-24	Lal PathLabs Employee Welfare Trust	ESOP	Sell	31,300
2026-08-24	Amit Aggarwal	Market	Sell	2,050
2026-08-20	Sanjay Kulshreshtha	ESOP	Buy	1,372
2026-08-18	Amit Aggarwal	ESOP	Buy	2,050
2026-08-18	Manoj Kumar Garg	Market	Sell	3,000
2026-08-18	Jai Prakash Meena	ESOP	Buy	7,000
2026-08-18	Manoj Kumar Garg	ESOP	Buy	3,000
2026-08-18	Lal PathLabs Employee Welfare Trust	ESOP	Sell	15,922

Sector Overview

HealthcareHospital & Healthcare Services

Dr. Lal Pathlabs Ltd. operates in the Healthcare sector under the Hospital & Healthcare Services industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

10 members across the board and senior leadership

Vinay Gujral

Company Secretary & Compliance Officer

—

Arvind Lal

Chairman

₹4.03 Cr

Mar '26

Vandana Lal

Whole Time Director

₹3.23 Cr

Mar '26

Arun Duggal

Non Executive Independent Director

₹98.50 L

Mar '26

Rajit Mehta

Non Executive Independent Director

₹49.00 L

Mar '26

Rohit Bhasin

Non Executive Independent Director

₹64.00 L

Mar '26

Somya Satsangi

Non Executive Independent Director

₹57.00 L

Mar '26

Archana Lal Erdmann

Promoter & Non-Executive Director

₹48.00 L

Mar '26

Rahul Sharma

Non Executive Director

₹53.00 L

Mar '26

Gurinder Singh Kalra

Non Executive Independent Director

₹44.50 L

Mar '25

LALPATHLAB Latest News

News

3 of 3 articles

COMPANY28 Aug 2026 · 11:14

Dr. Lal Pathlabs’ arm completes subscription of 30% stake in Neuome Technologies

Pursuant to completion of said subscription, Neuome has now become associate of the company

COMPANY20 Aug 2026 · 10:11

Dr. Lal Pathlabs’ arm incorporates subsidiary company in Uzbekistan

The objective of incorporation is to strengthen the group’s presence in Tashkent, Uzbekistan.

EQUITY2 Jul 2026 · 17:12

Dr. Lal PathLabs informs about newspaper publication

LALPATHLAB

₹1,885.75

-2.41%